ICEC0942 HCl
目录号: A16903
CDK7 inhibitor
ICEC0942,亦称为CT7001,是一种用于癌症治疗的口服生物可利用的选择性CDK7抑制剂。它选择性地抑制CDK7,其IC50为40nM;对CDK1、CDK2、CDK5和CDK9的IC50值分别高出45倍、15倍、230倍和30倍。
Discription | ICEC0942, also known as CT7001, is an Orally Bioavailable Selective Inhibitor of CDK7 for Cancer Treatment. It selectively inhibits CDK7, with an IC50 of 40nM; IC50 values for CDK1, CDK2, CDK5 and CDK9 were 45-, 15-, 230- and 30-fold higher. | ||
---|---|---|---|
Targets |
|
目录号 | A16903 |
---|---|
分子式 | C22H31ClN6O |
分子量 | 430.98 |
CAS号 | 1805789-54-1 |
SMILES | O[C@H]1CNCC[C@@H]1CNC2=NC3=C(C(C)C)C=NN3C(NCC4=CC=CC=C4)=C2.[H]Cl |
其他名称 | CT7001 |
储存条件 | Store lyophilized at -20ºC, keep desiccated. |
In vitro | DMSO | 76 mg/mL (176.34 mM) | |
Water | 76 mg/mL (176.34 mM) | ||
Ethanol | 13 mg/mL (30.16 mM) | ||
* <1 mg/ml means slightly soluble or insoluble. * Please note that Adooq tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations. |
Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
---|---|---|---|
0.1 mM | 23.2 mL | 116.01 mL | 232.03 mL |
0.5 mM | 4.64 mL | 23.2 mL | 46.41 mL |
1 mM | 2.32 mL | 11.6 mL | 23.2 mL |
5 mM | 0.46 mL | 2.32 mL | 4.64 mL |
Calculate the dilution required to prepare a stock solution. This equation is commonly abbreviated as: C1V1 = C2V2